Societies Should Provide The Journals That Scientists Need

Editor's Note: In a career spanning nearly 50 years, William J. Whelan--now a professor of biochemistry and molecular biology at the University of Miami--has published some 250 research papers and edited more than 20 scholarly books, his main interest being the biogenesis of polysaccharides and action patterns of the polysaccharide enzymes of metabolism. Throughout his career, Whelan also has served as editor and developer of more

Written byWilliam Whelan
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Editor's Note: In a career spanning nearly 50 years, William J. Whelan--now a professor of biochemistry and molecular biology at the University of Miami--has published some 250 research papers and edited more than 20 scholarly books, his main interest being the biogenesis of polysaccharides and action patterns of the polysaccharide enzymes of metabolism. Throughout his career, Whelan also has served as editor and developer of more than a dozen scientific journals, including the Biochemical Journal, Trends in Biochemical Sciences (TIBS), and FEBS Letters, a publication of the Federation of European Biochemical Societies. Since 1987, he has served as the first editor-in-chief of the prestigious FASEB Journal, published by the Federation of American Societies for Experimental Biology. Eugene Garfield, publisher of The Scientist and founder of the Philadelphia-based Institute for Scientific Information (ISI), has known Whelan since the 1950s. "My association with Bill goes back to a FASEB meeting in Atlantic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies